Pyxis Oncology Inc
NASDAQ:PYXS

Watchlist Manager
Pyxis Oncology Inc Logo
Pyxis Oncology Inc
NASDAQ:PYXS
Watchlist
Price: 1.69 USD 9.74% Market Closed
Market Cap: 100.5m USD
Have any thoughts about
Pyxis Oncology Inc?
Write Note

Intrinsic Value

PYXS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PYXS stock under the Base Case scenario is 1.03 USD. Compared to the current market price of 1.69 USD, Pyxis Oncology Inc is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PYXS Intrinsic Value
1.03 USD
Overvaluation 39%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Pyxis Oncology Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PYXS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PYXS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about PYXS?
Bearish
Neutral
Bullish

Fundamental Analysis

1.69 USD
+9.74%
+9.74%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Pyxis Oncology Inc
US
Biotechnology
Market Cap
100.5m USD
IPO
Oct 8, 2021
Employees
56
United States of America
Market Cap
100.5m USD
Industry
Biotechnology
IPO
Oct 8, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Pyxis Oncology Inc

Provide an overview of the primary business activities
of Pyxis Oncology Inc.

What unique competitive advantages
does Pyxis Oncology Inc hold over its rivals?

What risks and challenges
does Pyxis Oncology Inc face in the near future?

Has there been any significant insider trading activity
in Pyxis Oncology Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pyxis Oncology Inc.

Provide P/S
for Pyxis Oncology Inc.

Provide P/E
for Pyxis Oncology Inc.

Provide P/OCF
for Pyxis Oncology Inc.

Provide P/FCFE
for Pyxis Oncology Inc.

Provide P/B
for Pyxis Oncology Inc.

Provide EV/S
for Pyxis Oncology Inc.

Provide EV/GP
for Pyxis Oncology Inc.

Provide EV/EBITDA
for Pyxis Oncology Inc.

Provide EV/EBIT
for Pyxis Oncology Inc.

Provide EV/OCF
for Pyxis Oncology Inc.

Provide EV/FCFF
for Pyxis Oncology Inc.

Provide EV/IC
for Pyxis Oncology Inc.

Show me price targets
for Pyxis Oncology Inc made by professional analysts.

What are the Revenue projections
for Pyxis Oncology Inc?

How accurate were the past Revenue estimates
for Pyxis Oncology Inc?

What are the Net Income projections
for Pyxis Oncology Inc?

How accurate were the past Net Income estimates
for Pyxis Oncology Inc?

What are the EPS projections
for Pyxis Oncology Inc?

How accurate were the past EPS estimates
for Pyxis Oncology Inc?

What are the EBIT projections
for Pyxis Oncology Inc?

How accurate were the past EBIT estimates
for Pyxis Oncology Inc?

Compare the revenue forecasts
for Pyxis Oncology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pyxis Oncology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pyxis Oncology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pyxis Oncology Inc compared to its peers.

Compare the P/E ratios
of Pyxis Oncology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Pyxis Oncology Inc with its peers.

Analyze the financial leverage
of Pyxis Oncology Inc compared to its main competitors.

Show all profitability ratios
for Pyxis Oncology Inc.

Provide ROE
for Pyxis Oncology Inc.

Provide ROA
for Pyxis Oncology Inc.

Provide ROIC
for Pyxis Oncology Inc.

Provide ROCE
for Pyxis Oncology Inc.

Provide Gross Margin
for Pyxis Oncology Inc.

Provide Operating Margin
for Pyxis Oncology Inc.

Provide Net Margin
for Pyxis Oncology Inc.

Provide FCF Margin
for Pyxis Oncology Inc.

Show all solvency ratios
for Pyxis Oncology Inc.

Provide D/E Ratio
for Pyxis Oncology Inc.

Provide D/A Ratio
for Pyxis Oncology Inc.

Provide Interest Coverage Ratio
for Pyxis Oncology Inc.

Provide Altman Z-Score Ratio
for Pyxis Oncology Inc.

Provide Quick Ratio
for Pyxis Oncology Inc.

Provide Current Ratio
for Pyxis Oncology Inc.

Provide Cash Ratio
for Pyxis Oncology Inc.

What is the historical Revenue growth
over the last 5 years for Pyxis Oncology Inc?

What is the historical Net Income growth
over the last 5 years for Pyxis Oncology Inc?

What is the current Free Cash Flow
of Pyxis Oncology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pyxis Oncology Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pyxis Oncology Inc

Current Assets 148.9m
Cash & Short-Term Investments 144.8m
Other Current Assets 4.1m
Non-Current Assets 46.4m
PP&E 22.8m
Intangibles 23.6m
Current Liabilities 20.3m
Accounts Payable 4.9m
Accrued Liabilities 15.5m
Non-Current Liabilities 21.3m
Long-Term Debt 117k
Other Non-Current Liabilities 21.2m
Efficiency

Earnings Waterfall
Pyxis Oncology Inc

Revenue
16.1m USD
Cost of Revenue
-475k USD
Gross Profit
15.7m USD
Operating Expenses
-82.8m USD
Operating Income
-67.2m USD
Other Expenses
9.8m USD
Net Income
-57.4m USD

Free Cash Flow Analysis
Pyxis Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PYXS Profitability Score
Profitability Due Diligence

Pyxis Oncology Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

Pyxis Oncology Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

PYXS Solvency Score
Solvency Due Diligence

Pyxis Oncology Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
67/100
Solvency
Score

Pyxis Oncology Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PYXS Price Targets Summary
Pyxis Oncology Inc

Wall Street analysts forecast PYXS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYXS is 10.05 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

Lowest
Price Target
5.05 USD
199% Upside
Average
Price Target
10.05 USD
495% Upside
Highest
Price Target
13.65 USD
708% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PYXS?

Click here to dive deeper.

Dividends

Pyxis Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PYXS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PYXS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one PYXS stock?

The intrinsic value of one PYXS stock under the Base Case scenario is 1.03 USD.

Is PYXS stock undervalued or overvalued?

Compared to the current market price of 1.69 USD, Pyxis Oncology Inc is Overvalued by 39%.

Back to Top